Search Results - "Yassine, Hadi M"

Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 by Younes, Nadin, Al-Sadeq, Duaa W, Al-Jighefee, Hadeel, Younes, Salma, Al-Jamal, Ola, Daas, Hanin I, Yassine, Hadi M, Nasrallah, Gheyath K

“…The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A…”
Get full text

Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms by Smatti, Maria K, Cyprian, Farhan S, Nasrallah, Gheyath K, Al Thani, Asmaa A, Almishal, Ruba O, Yassine, Hadi M

“…For a long time, viruses have been shown to modify the clinical picture of several autoimmune diseases, including type 1 diabetes (T1D), systemic lupus…”
Get full text

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar by Chemaitelly, Hiam, Tang, Patrick, Hasan, Mohammad R, AlMukdad, Sawsan, Yassine, Hadi M, Benslimane, Fatiha M, Al Khatib, Hebah A, Coyle, Peter, Ayoub, Houssein H, Al Kanaani, Zaina, Al Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar H, Latif, Ali N, Shaik, Riyazuddin M, Abdul Rahim, Hanan F, Nasrallah, Gheyath K, Al Kuwari, Mohamed G, Al Romaihi, Hamad E, Butt, Adeel A, Al-Thani, Mohamed H, Al Khal, Abdullatif, Bertollini, Roberto, Abu-Raddad, Laith J

“…In a test-negative, case–control study involving more than 900,000 participants in Qatar, vaccine effectiveness peaked at 77.5% in the first month after the…”
Get full text

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections by Altarawneh, Heba N., Chemaitelly, Hiam, Ayoub, Houssein H., Tang, Patrick, Hasan, Mohammad R., Yassine, Hadi M., Al-Khatib, Hebah A., Smatti, Maria K., Coyle, Peter, Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar H., Latif, Ali N., Shaik, Riyazuddin M., Abdul-Rahim, Hanan F., Nasrallah, Gheyath K., Al-Kuwari, Mohamed G., Butt, Adeel A., Al-Romaihi, Hamad E., Al-Thani, Mohamed H., Al-Khal, Abdullatif, Bertollini, Roberto, Abu-Raddad, Laith J.

“…A study in Qatar assessed the effectiveness of previous infection, vaccination, and both against symptomatic SARS-CoV-2 caused by omicron BA.1 and BA.2 and…”
Get full text

Nanomedicine for Cancer by Younis, Nour K, Yassine, Hadi M, Eid, Ali H

Get more information

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar by Chemaitelly, Hiam, Ayoub, Houssein H., AlMukdad, Sawsan, Coyle, Peter, Tang, Patrick, Yassine, Hadi M., Al-Khatib, Hebah A., Smatti, Maria K., Hasan, Mohammad R., Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul-Rahim, Hanan F., Nasrallah, Gheyath K., Al-Kuwari, Mohamed Ghaith, Butt, Adeel A., Al-Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al-Khal, Abdullatif, Bertollini, Roberto, Abu-Raddad, Laith J.

“…SARS-CoV-2 Omicron BA.1 and BA.2 subvariants are genetically divergent. We conducted a matched, test-negative, case-control study to estimate duration of…”
Get full text

Viral-Induced Enhanced Disease Illness by Smatti, Maria K, Al Thani, Asmaa A, Yassine, Hadi M

“…Understanding immune responses to viral infections is crucial to progress in the quest for effective infection prevention and control. The host immunity…”
Get full text

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences by Hoteit, Reem, Yassine, Hadi M

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that belongs to the coronavirus family and is the cause of coronavirus disease 2019…”
Get full text

Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar by Smatti, Maria K, Yassine, Hadi M, AbuOdeh, Raed, AlMarawani, Asmaa, Taleb, Sara A, Althani, Asmaa A, Nasrallah, Gheyath K

“…The Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis. EBV is highly prevalent lymphotropic herpesvirus and has been linked to…”
Get full text

Seasonality of Respiratory Viral Infections: Will COVID-19 Follow Suit? by Audi, Amani, AlIbrahim, Malak, Kaddoura, Malak, Hijazi, Ghina, Yassine, Hadi M, Zaraket, Hassan

“…Respiratory viruses, including coronaviruses, are known to have a high incidence of infection during winter, especially in temperate regions. Dry and cold…”
Get full text

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants by Altarawneh, Heba N., Chemaitelly, Hiam, Ayoub, Houssein H., Hasan, Mohammad R., Coyle, Peter, Yassine, Hadi M., Al-Khatib, Hebah A., Smatti, Maria K., Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar H., Latif, Ali N., Shaik, Riyazuddin M., Abdul-Rahim, Hanan F., Nasrallah, Gheyath K., Al-Kuwari, Mohamed G., Butt, Adeel A., Al-Romaihi, Hamad E., Al-Thani, Mohamed H., Al-Khal, Abdullatif, Bertollini, Roberto, Tang, Patrick, Abu-Raddad, Laith J.

“…Epidemiologic data from Qatar show that any previous SARS-CoV-2 infection was 35% effective in preventing reinfection with omicron BA.4 and BA.5 subvariants…”
Get full text

Immune Modulatory Effects of Vitamin D on Viral Infections by Siddiqui, Maheen, Manansala, Judhell S, Abdulrahman, Hana A, Nasrallah, Gheyath K, Smatti, Maria K, Younes, Nadin, Althani, Asmaa A, Yassine, Hadi M

“…Viral infections have been a cause of mortality for several centuries and continue to endanger the lives of many, specifically of the younger population…”
Get full text

Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin by Andrews, Sarah F., Chambers, Michael J., Schramm, Chaim A., Plyler, Jason, Raab, Julie E., Kanekiyo, Masaru, Gillespie, Rebecca A., Ransier, Amy, Darko, Sam, Hu, Jianfei, Chen, Xuejun, Yassine, Hadi M., Boyington, Jeffrey C., Crank, Michelle C., Chen, Grace L., Coates, Emily, Mascola, John R., Douek, Daniel C., Graham, Barney S., Ledgerwood, Julie E., McDermott, Adrian B.

“…Vaccine-induced memory B cell responses to evolving viruses like influenza A involve activation of pre-existing immunity and generation of new responses. To…”
Get full text

Will influenza A(H3N8) cause a major public health threat? by Yassine, Hadi M., Smatti, Maria K.

“…•On April 27, 2022, China reported the first-ever human influenza A(H3N8) infection.•Previous studies indicated a possible circulation of the H3N8 in humans in…”
Get full text

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera by Ngwuta, Joan O, Chen, Man, Modjarrad, Kayvon, Joyce, M Gordon, Kanekiyo, Masaru, Kumar, Azad, Yassine, Hadi M, Moin, Syed M, Killikelly, April M, Chuang, Gwo-Yu, Druz, Aliaksandr, Georgiev, Ivelin S, Rundlet, Emily J, Sastry, Mallika, Stewart-Jones, Guillaume B E, Yang, Yongping, Zhang, Baoshan, Nason, Martha C, Capella, Cristina, Peeples, Mark E, Ledgerwood, Julie E, McLellan, Jason S, Kwong, Peter D, Graham, Barney S

“…Respiratory syncytial virus (RSV) is estimated to claim more lives among infants <1 year old than any other single pathogen, except malaria, and poses a…”
Get more information

Structural and genetic basis for development of broadly neutralizing influenza antibodies by Lingwood, Daniel, McTamney, Patrick M., Yassine, Hadi M., Whittle, James R. R., Guo, Xiaoti, Boyington, Jeffrey C., Wei, Chih-Jen, Nabel, Gary J.

“…The events leading to the generation of broadly neutralizing antibodies to influenza viruses, which may hold the key to developing a universal flu vaccine, are…”
Get full text

Expression profile of MicroRNA: An Emerging Hallmark of Cancer by Zaheer, Uzma, Faheem, Muhammed, Qadri, Ishtiaq, Begum, Nargis, Yassine, Hadi M, Al Thani, Asmaa A, Mathew, Shilu

“…MicroRNA (miRNAs), a class of small, endogenous non-coding RNA molecules of about 21-24 nucleotides in length, have unraveled a new modulatory network of RNAs…”
Get more information

Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities by Wehbe, Zena, Wehbe, Maya, Iratni, Rabah, Pintus, Gianfranco, Zaraket, Hassan, Yassine, Hadi M, Eid, Ali H

“…As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, there is an urgent need for vaccines and therapeutics to reduce…”
Get full text

Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage by Chemaitelly, Hiam, Ayoub, Houssein H., Coyle, Peter, Tang, Patrick, Yassine, Hadi M., Al-Khatib, Hebah A., Smatti, Maria K., Hasan, Mohammad R., Al-Kanaani, Zaina, Al-Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul-Rahim, Hanan F., Nasrallah, Gheyath K., Al-Kuwari, Mohamed Ghaith, Butt, Adeel A., Al-Romaihi, Hamad Eid, Al-Thani, Mohamed H., Al-Khal, Abdullatif, Bertollini, Roberto, Abu-Raddad, Laith J.

“…There is significant genetic distance between SARS-CoV-2 Omicron (B.1.1.529) variant BA.1 and BA.2 sub-lineages. This study investigates immune protection of…”
Get full text

Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children by Mathew, Shilu, Smatti, Maria K., Al Ansari, Khalid, Nasrallah, Gheyath K., Al Thani, Asmaa A., Yassine, Hadi M.

“…Acute gastroenteritis remains a major cause of morbidity and mortality among young children worldwide. It accounts for approximately 1.34 million deaths…”
Get full text